1 September 2024 false No description of principal activity Taxfiler 2024.6 14286007 business:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 14286007 2024-08-31 14286007 2024-09-01 2025-08-31 14286007 business:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 14286007 business:FilletedAccounts 2024-09-01 2025-08-31 14286007 2025-08-31 14286007 business:Director1 2024-09-01 2025-08-31 14286007 2024-08-31 14286007 core:WithinOneYear 2025-08-31 14286007 core:WithinOneYear 2024-08-31 14286007 core:ShareCapital core:PreviouslyStatedAmount 2025-08-31 14286007 core:ShareCapital core:PreviouslyStatedAmount 2024-08-31 14286007 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-08-31 14286007 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-08-31 14286007 core:PreviouslyStatedAmount 2025-08-31 14286007 core:PreviouslyStatedAmount 2024-08-31 14286007 business:SmallEntities 2024-09-01 2025-08-31 14286007 countries:EnglandWales 2024-09-01 2025-08-31 14286007 core:MotorVehicles 2024-09-01 2025-08-31 14286007 core:ComputerEquipment 2024-09-01 2025-08-31 14286007 core:MotorVehicles 2024-08-31 14286007 core:FurnitureFittings 2024-08-31 14286007 core:MotorVehicles 2025-08-31 14286007 core:FurnitureFittings 2025-08-31 14286007 core:FurnitureFittings 2024-09-01 2025-08-31 14286007 business:OrdinaryShareClass1 2024-09-01 2025-08-31 14286007 business:OrdinaryShareClass1 2023-09-01 2024-08-31 14286007 2023-09-01 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14286007 (England and Wales)
Pharmarly Ltd Unaudited accounts for the year ended 31 August 2025
Pharmarly Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Pharmarly Ltd Company Information for the year ended 31 August 2025
Director
HUEY WONG
Company Number
14286007 (England and Wales)
- 3 -
Pharmarly Ltd Statement of financial position as at 31 August 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
11,388
13,251
Investments
5
20,000
20,000
31,388
33,251
Current assets
Cash at bank and in hand
1,715
2,261
Creditors: amounts falling due within one year
6
(27,402)
(32,901)
Net current liabilities
(25,687)
(30,640)
Net assets
5,701
2,611
Capital and reserves
Called up share capital
7
1
1
Profit and loss account
5,700
2,610
Shareholders' funds
5,701
2,611
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 May 2026 and were signed on its behalf by
HUEY WONG Director Company Registration No. 14286007
- 4 -
Pharmarly Ltd Notes to the Accounts for the year ended 31 August 2025
1
Statutory information
Pharmarly Ltd is a private company, limited by shares, registered in England and Wales, registration number 14286007.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
1
Computer equipment
1
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Tangible fixed assets
Motor vehicles
Fixtures & fittings
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 September 2024
15,000
1,814
16,814
At 31 August 2025
15,000
1,814
16,814
Depreciation
At 1 September 2024
3,000
563
3,563
Charge for the year
1,500
363
1,863
At 31 August 2025
4,500
926
5,426
Net book value
At 31 August 2025
10,500
888
11,388
At 31 August 2024
12,000
1,251
13,251
5
Investments
Other investments
£
Valuation at 1 September 2024
20,000
Valuation at 31 August 2025
20,000
- 5 -
Pharmarly Ltd Notes to the Accounts for the year ended 31 August 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Loans from directors
27,402
32,901
7
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1
1
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 6 -